The American Gastroenterology Association (AGA) updated its clinical practice guidelines for managing hepatitis B ...
Gladys Antelo-Allen of Camden Coalition discusses a new skills lab offering accessible learning modules with 12 microlessons ...
The FDA removed previously issued draft guidance on diversity in clinical trials from its website without public notice or ...
Roche’s PATHWAY HER2 (4B5) test helps identify patients with HER2-ultralow breast cancer, who may be eligible for targeted ...
Robert F. Kennedy Jr sat before the Senate for 2 separate hearings, to decide the fate of his confirmation as secretary of ...
Private equity hospital acquisitions in the US were associated with declines in patient care experience, particularly in ...
Patients living with HIV who were frail or prefrail had significantly poorer oral health-related quality of life compared with patients with HIV who were robust.
Avtozma, the third biosimilar to Actemra, has received FDA approval for multiple inflammatory diseases and COVID-19, potentially expanding treatment access for patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback